Plus Therapeutics issues Series F Preferred Stock to Chairman with 50M votes per share on reverse split proposals

PLUS THERAPEUTICS, INC.

Issued one share of Series F Preferred Stock to Chairman Richard J. Hawkins for $1,000 cash.
Preferred stock carries 50,000,000 votes per share, voting only on reverse stock split proposals in proportion to common stock votes.
No conversion rights, no dividends, no liquidation preference; redeemable at board discretion or automatically upon stockholder approval of reverse split.
Issuance exempt from registration under Rule 506 of Regulation D.
Certificate of Designation filed with Delaware Secretary of State on March 3, 2023.

item 1.01 item 5.03 item 3.02 item 3.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

PLUS THERAPEUTICS, INC.: Filed a certificate of designation for Preferred Stock with specific voting rights and redemption provisions (effective 2023-03-03).

Change: charter amendment
Effective: 2023-03-03

Exact text from the filing

On March 3, 2023, the Company filed a certificate of designation (the “Certificate of Designation”) with the Secretary of State of the State of Delaware, effective as of the time of filing, designating the rights, preferences, privileges and restrictions of the Preferred Stock.

View on SEC.gov

73 governance changes filed in the last 30 days. Browse all governance changes →

PLUS THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001193125-23-060090

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.